SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX has rallied to a fresh 52-week high as traders position ahead of the Q3 report, focusing on BRIUMVIs sales growth and possible guidance changes. The move has also fueled unconfirmed Sanofi buyout and short-squeeze speculation, while some traders caution that the rally may have priced in strong results.

Lennar Corp. engages in the provision of real estate related financial and investment management services. It operates through the following segments: Homebuilding, Financial Services, Multifamily, and Lennar Other. The Homebuilding segment refers to the construction and sale of single-family attached and detached homes and the purchase, development, and sale of residential land directly and through entities. The Financial Services segment focuses on mortgage financing, title, and closing services for buyers. The Multifamily segment is involved in the development, construction, and property management of multifamily rental properties. The Lennar Other segment includes funds, asset management platform, and strategic investments in technology companies. The company was founded in 1954 and is headquartered in Miami, FL.

Lennar Corp. - Ordinary Shares - Class A

Lennar Corp.

Berkshires disclosed accumulation of a large Lennar stake has fueled bargain-buying interest, but traders are debating it against Hunterbrooks short-report allegations about Lennars transactions with spinoff Millrose. The dispute adds to concerns over weak results and outlook, pressured affordability, and elevated mortgage rates.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

A Northland upgrade citing C3 Code as a potential growth driver for agentic AI has renewed interest in C3.ai, alongside unusual call-option activity and short-squeeze speculation. Traders are divided between optimism about the product and enterprise AI demand, and concern over declining revenue and continued losses.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. The firm offers annealing and gate-model quantum computing technologies. It provides professional services that assist customers in identifying and implementing quantum computing applications and selling quantum computer systems to customers. The company was founded by Eric Ladizinsky in 1999 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave shares are drawing attention amid a steep selloff across quantum-computing stocks, with traders questioning whether high valuations, limited near-term commercialization and competition from classical AI can support the sector ahead of Q3 results. Some see the pullback as a buying opportunity, while others expect more downside.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in London, Canada.

Aduro Clean Technologies Inc

Aduros reported pilot results showing high condensable-hydrocarbon yields across polypropylene and mixed polyolefin feeds are driving discussion, alongside progress toward its planned first-of-a-kind facility. Bulls see the results and engineering work as validation of its plastics-recycling technology, while skeptics argue that yields do not establish commercial economics or scalability.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

Discussion centers on REalloys potential role in a North American rare-earth and magnet supply chain, with traders pointing to U.S. defense sourcing restrictions taking effect in 2027 and the companys Army-linked Tooele project and Tanbreez offtake as longer-term catalysts. Bulls see strategic demand upside, while bears focus on the lack of recent operational updates, execution and dilution risks, and sharp volatility.

Backblaze, Inc. operates as a cloud provider for businesses and consumers to store, use, and protect their data. The firm provides a foundation for businesses, developers, IT professionals, and individuals to store, backup, and archive data, host content, manage media, and build their applications. It also offers B2 Cloud Storage and Computer Backup services. The company was founded by Timothy Nufire, Gleb Budman, Charles Jones, Kwok Hang Ng, Brian Wilson, Nilay Patel and Damon Uyeda in 2007 and is headquartered in San Francisco, CA.

Backblaze Inc - Ordinary Shares - Class A

BLZE is under pressure after a steep pullback, with traders pointing to broader tech weakness and CoreWeaves decline while positioning around the upcoming earnings report. The community is split between dip-buyers betting on strong results or new contracts and cautious traders concerned that earnings could bring further losses.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is falling amid a broad semiconductor selloff that traders attribute largely to Intels weak forward guidance, with some also pointing to bearish put-option activity. The community is split between buying the pullback and expecting further downside, while noting the drop appears tied more to sector pressure than a clear Qualcomm-specific catalyst.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

MAGS is drawing attention amid a pullback and debate over whether mega-cap tech can justify its heavy AI spending, with traders citing cash-flow pressure and bubble risk. Others view the weakness as a buying opportunity and expect money to rotate back from semiconductors into the Magnificent Seven.

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002, and is headquartered in Cambridge, MA.

Alnylam Pharmaceuticals Inc

Ionis and AstraZenecas Wainua Phase 3 ATTR-CM trial missed its primary endpoint, drawing attention to potential competitive read-through for Alnylams TTR franchise and upcoming cardiomyopathy pipeline. Traders are divided: some view the failure as removing a rival and strengthening Amvuttras position, while others see it as raising broader questions about TTR silencers and increasing risk around Alnylams development plans.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stepan Q3 2026 Earnings Call Transcript

Stepan (NYSE:SCL) reported third-quarter financial results on Wednesday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. Forread more...

Stepan Co. (SCL) Beats Q3 Earnings and Revenue Estimates

Stepan Co. (SCL) delivered earnings and revenue surprises of +28.77% and +9.12%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Stepan Increases Quarterly Cash Dividend, Marking the 59th Consecutive Year of Increases

Stepan Increases Quarterly Cash Dividend, Marking the 59th Consecutive Year of Increases Stepan Increases Quarterly Cash Dividend, Marking the 59th Consecutive Year of IncreasesPR NewswireNORTHBROOK, Ill., Oct. 28, 2026 NORTHBROOK, Ill., Oct. 28, 2026 /PRNewswire/ -- Stepan Company (NYSE: SCL...

Stepan Reports Third Quarter 2026 Results

Stepan Reports Third Quarter 2026 Results Stepan Reports Third Quarter 2026 ResultsPR NewswireNORTHBROOK, Ill., Oct. 28, 2026 NORTHBROOK, Ill., Oct. 28, 2026 /PRNewswire/ -- Stepan Company (NYSE: SCL) today reported: Third Quarter 2026 HighlightsReported net income was $17.8 million, up 64% versus...

Stepan to Announce Third Quarter 2026 Results on October 28, 2026

Stepan to Announce Third Quarter 2026 Results on October 28, 2026 Stepan to Announce Third Quarter 2026 Results on October 28, 2026PR NewswireNORTHBROOK, Ill., Oct. 7, 2026NORTHBROOK, Ill., Oct. 7, 2026 /PRNewswire/ -- Stepan Company (NYSE: SCL) will issue its third quarter 2026 earnings results on...

Is Avient (AVNT) Stock Outpacing Its Basic Materials Peers This Year?

Here is how Avient (AVNT) and Stepan Co. (SCL) have performed compared to their sector so far this year.

Best Momentum Stock to Buy for September 30th

SCL and ACIU made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 30, 2026.

New Strong Buy Stocks for September 30th

MSGM, GTN, HLIO, EMBJ and SCL have been added to the Zacks Rank #1 (Strong Buy) List on September 30, 2026.

Rival Ukrainian Agencies In Lengthy Street Shootout, Officers Wounded

Rival Ukrainian Agencies In Lengthy Street Shootout, Officers Wounded

 A bizarre mini civil war of sorts has erupted among rival Ukrainian security agencies, complete with a wild street shootout and police standoff which has threatened to create more political scandal for President...

Are Options Traders Betting on a Big Move in Stepan Stock?

Investors need to pay close attention to SCL stock based on the movements in the options market lately.

• Reported GAAP EPS of $0.94 up 95.83% YoY
• Reported revenue of $692.15M up 17.26% YoY
• Stepan believes it will deliver full year Adjusted EBITDA growth, positive free cash flow, and continue to de-leverage the balance sheet in 2026, despite ongoing and significant market uncertainties and challenges.

Stepan's YTD 2026 net loss included a $76.1M restructuring charge; Q3 free cash flow was $8.2M, negatively impacted by higher working capital requirements, with lower Crop Productivity demand and supply chain disruptions.

Stepan's adjusted EBITDA increased 18% as Surfactant earnings were driven by sales volume growth and margin recovery; broad-based Surfactant volume growth and $28.5M land-sale proceeds will be used to pay down debt.

Stepan Co. engages in the manufacture and sale of specialty and intermediate chemicals. It operates through the following segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment products are used in consumer and industrial cleaning and disinfection products, agricultural products, lubricating ingredients, oil field chemicals, and other applications. The Polymers segment deals mainly with rigid foam for thermal insulation in the construction industry, plastics, building materials, refrigeration systems, and CASE applications. The Specialty Products segment consists of chemicals used in food, flavoring, nutritional supplements, and pharmaceutical applications. The company was founded by Alfred C. Stepan Jr. in 1932 and is headquartered in Northbrook, IL.

Stepan Co.

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$69.61
Prev Close	$69.99
Open	$70.00
Dividend Yield	3.27%
50-Day Moving Average	$63.00
Beta	0.96
Avg. Volume	156,471.60
PE Ratio	373.04

52-Week High	$70.81
52-Week Low	$41.82
Market Capitalization	$1.58B
EPS (Annual)	$2.05
Price to Book	1.31
Revenue Per Employee	$1M

Feed

News

Sentiment

Earnings

Fundamentals

Info

SCL Fundamentals